2.42
0.07 (2.98%)
0.07 (2.98%)
Upgrade to Real-Time
Regular Market
Volume | 31,490 |
|
|||||
News | - | ||||||
Day High | 2.44 | Low High |
|||||
Day Low | 2.26 |
Best deals to access real time data! |
Big Cap Pro
Monthly Subscription
for only
|
Small Cap Basic
Monthly Subscription
for only
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
VAT not included
|
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Celsion Corporation | CLSN | NASDAQ | Common Stock |
Price Change | Change Percent | Stock Price | Last Traded
![]() |
|
---|---|---|---|---|
0.07 | 2.98% | 2.42 | 14:43:37 |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
2.27 | 2.26 | 2.44 | 2.35 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
160 | 31,490 | $ 2.35 | $ 74,109 | - | 0.3116 - 7.68 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
14:47:09 | 66 | $ 2.40 | USD |
Celsion Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 17.18M | 7.10M | 7.06M | $ 500.00k | $ - | -5.79 | -0.50 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | $ - | - | 125.00k | 7.40% |
Celsion News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CLSN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 2.60 | 2.6001 | 2.2301 | 2.37 | 41,224 | -0.18 | -6.92% |
1 Month | 3.02 | 3.3594 | 2.2301 | 2.74 | 47,026 | -0.60 | -19.87% |
3 Months | 4.53 | 7.68 | 2.2301 | 5.37 | 341,376 | -2.11 | -46.58% |
6 Months | 0.7299 | 7.68 | 0.3116 | 2.16 | 488,751 | 1.69 | 231.55% |
1 Year | 1.11 | 7.68 | 0.3116 | 1.41 | 845,313 | 1.31 | 118.02% |
3 Years | 2.06 | 7.68 | 0.3116 | 1.92 | 2,587,308 | 0.36 | 17.48% |
5 Years | 3.50 | 7.68 | 0.3116 | 2.22 | 1,912,788 | -1.08 | -30.86% |
Celsion Description
Celsion Corp is active in the biotechnology sector. The company acts as a drug developer with product candidates like ThermoDox, a heat-activated liposomal encapsulation of doxorubicin. It is in a clinical trial for the treatment of primary liver cancer. Its pipeline also includes GEN-1, a deoxyribonucleic acid (DNA) mediated immunotherapy for the localized treatment of ovarian and brain cancers. |